COVID-19 Implications: Dental Supplies Industries Featuring concise text and easy-to-read charts, this white paper from iData Research provides a quick overview of COVID-19’s impact across a range of dental markets in the US, Europe, Latin America, and Asia-Pacific.
|
White Paper: The Five Forces of Genomic Medicine In this white paper, BIS Research explains the five forces that can drive value and implementation of genomics in medical practice.
|
White Paper: 7 Leading Medical Publishers to Watch Based on Simba Information’s report Global Medical Publishing 2019-2023, this white paper highlights the top seven medical publishers, the key challenges they face and their strategies for the future.
|
Five Surprising Facts About the IVD Market This white paper, Five Surprising Facts About the IVD Market, provides some of the interesting findings from Kalorama Information's 2018 report, The Worldwide Market for Diagnostic Tests, 11th Edition.
|
What You May Have Missed at AACC 2018 As premier researchers of the IVD industry, Kalorama Information attended the American Association for Clinical Chemistry (AACC) in Chicago and produced a white paper of key developments in the meeting.
|
101 Companies in Point of Care Diagnostics Point of care is one of the most dynamic categories of the in vitro diagnostics industry. This complimentary white paper from Kalorama Information lists 101 companies in the field and provides contact information.
|
8 Potential IVD Market Disruptors This white paper from Kalorama Information details long-term trends that could influence the future direction or completely change IVD markets.
|
50 Notes from the J.P. Morgan Healthcare Conference 2018 The J.P. Morgan Healthcare Conference is the largest and most important meeting of healthcare and those who fund healthcare. This white paper reveals the highlights and news made in the biopharmaceutical and diagnostics industries at the 2018 meeting.
|
Four Unstoppable Trends in IVD Kalorama Information’s white paper, Four Unstoppable Trends in IVD, is based on our reporting of 2017 market events and competitive moves in in vitro diagnostics (IVD). The white paper identifies four important market trends that IVD market watchers should be aware of.
|
101 Companies in Immunoassays This white paper lists companies currently participating in the immunoassays market. It is useful for anyone interested in IVD.
|
15 Biotech Companies to Watch This e-book is a useful resource whether you’re interested in learning about several top biotech companies, or want a quick overview of what’s happening in the biotechnology industry.
|
What You May Have Missed at AACC 2017 The American Association for Clinical Chemistry is the largest meeting of lab professionals and the IVD companies that supply them. This year’s AACC in San Diego featured many innovative seminars and product offerings. Kalorama provides this summary of the meeting.
|
Major NGS Platforms & Markets The white paper describes new product developments, trends, Zika developments and testing science news from the American Association for Clinical Chemistry Clinical Expo, the largest meeting of lab professionals and IVD suppliers, in Philadelphia.
|
Top 5 IVD Trends to Watch in 2017 The white paper describes the top 5 trends in the in vitro diagnostics market of 2016. Kalorama’s report, The Worldwide Market for In Vitro Diagnostic Tests, 10th Edition, covers the market for IVD products.
|
Top 5 Next-Generation Sequencing Trends of 2016 The white paper describes the top 5 investment, regulatory, product development and regional trends in the next-generation sequencing market.
|
Meet the Top 7 Companies in POC Diagnostics Point of care systems are designed to deliver test results in a location and timing to be useful during a patient visit. Hundreds of companies compete in this market, and there is brisk opportunity for vendors. That being said, there are some companies that dominate point of care diagnostics, and market-watchers should know about them.
|
Three Trends to Watch in Life Sciences In this white paper, discover three of the most important life sciences industry trends. These trends are changing healthcare delivery, patient experience/outcome and which healthcare companies will prosper.
|
Beyond Oncotype: Cancer Test Commercialization Grows This white paper provides a look at commercialized testing services for cancer diagnostics. Many new cancer diagnostic tests that are being developed and offered today are highly complex assays, and it may not be easy to put the reagents for these tests into a kit for shipment to clinical laboratories.
|
5 Cutting-Edge Trends in Molecular Diagnostics Molecular diagnostics is one of the fastest growth segments in clinical diagnostics. In the past few years, the market has experienced rapid change with new trends emerging in the industry. In this white paper, you will learn about the top 5 trends in the molecular diagnostics industry
|
Sizing Up the Opportunity in Lab-Developed Tests Diagnostics tests for cancer screening are in high demand, and new tests are being launched all the time. This white paper from Kalorama Information provides authoritative analysis of the market for cancer diagnostic tests with expert market sizing and opportunity assessment.
|
Widening the Net: Co-Brand Credit Card Growth Opportunities In this white paper, discover three of the most important life sciences industry trends. These trends are changing healthcare delivery, patient experience/outcome and which healthcare companies will prosper.
|
Healthcare IT, Patient Monitoring & Telemedicine The digital revolution in healthcare IT includes remote patient ponitoring and telemedicine. In this white paper, learn about the technical, investment, and consumer aspects of this dynamic marketplace.
|